Description
FDA-approved GHRH analogue for HIV-associated lipodystrophy. Reduces visceral fat and improves body composition.
FDA-approved GHRH analogue for HIV-associated lipodystrophy. Reduces visceral fat and improves body composition.
FDA-approved GHRH analogue for HIV-associated lipodystrophy. Reduces visceral fat and improves body composition.
Reviews
There are no reviews yet.